Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker

C. L. Ursini, E. Omodeo Salè, A. M. Fresegna, A. Ciervo, C. Jemos, R. Maiello, G. Buresti, C. Colosio, F. M. Rubino, Stefan Mandić-Rajčević, P. Chiarella, D. Carbonari, P. Delrio, P. Maiolino, P. Marchetti, R. Boccia, S. Iavicoli, D. Cavallo

Research output: Contribution to journalArticle

Abstract

Health-care personnel handling antineoplastic drugs could be at risk for adverse health effects. We aimed to evaluate genotoxic and cytotoxic effects of antineoplastic drug exposure of personnel preparing and administering such drugs in three Oncology Hospitals in Italy enrolling 42 exposed subjects and 53 controls. Furthermore, we aimed to study the possible influence of XRCC1 and hOGG1 DNA repair genes polymorphisms on genotoxicity induced on buccal cells. We performed workplace and personal monitoring of some drugs and used exposure diary informations to characterize the exposure. Urinary 5-FU metabolite (α-fluoro-β-alanine) was measured. Buccal Micronucleus Cytome (BMCyt) assay was used to evaluate DNA damage and other cellular anomalies. GEM and 5-FU contamination was found in 68% and 42% of wipe/swab samples respectively. GEM deposition was found on workers’ pads while no α-fluoro-β-alanine was found. BMCyt-assay showed higher genotoxicity and cytotoxicity on nurses administering antineoplastics than on preparators and controls. Among micronucleus (MN) positive (with MN frequency higher than 1.5‰) exposed subjects, the percentage of those carrying XRCC1 mut/het genotype was higher than in MN positive-controls. Using the sensitive BMCyt assay, we demonstrated that handling antineoplastics still represents a potential occupational health risk for workers that should be better trained/informed regarding such risks.

Original languageEnglish
Pages (from-to)20-26
Number of pages7
JournalToxicology Letters
Volume316
DOIs
Publication statusPublished - Nov 1 2019

Fingerprint

Micronucleus Tests
Cheek
Biomarkers
Occupational Exposure
Antineoplastic Agents
Assays
Air cushion vehicles
Fluorouracil
Alanine
Occupational risks
Personnel
Oncology
Drug Monitoring
Health risks
DNA
Occupational Health
Cytotoxicity
Metabolites
Polymorphism
Health care

Keywords

  • Antineoplastic drug handling
  • Buccal micronucleus cytome (BMCyt) assay
  • Nurses
  • Workplace monitoring

ASJC Scopus subject areas

  • Toxicology

Cite this

Antineoplastic drug occupational exposure : a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker. / Ursini, C. L.; Omodeo Salè, E.; Fresegna, A. M.; Ciervo, A.; Jemos, C.; Maiello, R.; Buresti, G.; Colosio, C.; Rubino, F. M.; Mandić-Rajčević, Stefan; Chiarella, P.; Carbonari, D.; Delrio, P.; Maiolino, P.; Marchetti, P.; Boccia, R.; Iavicoli, S.; Cavallo, D.

In: Toxicology Letters, Vol. 316, 01.11.2019, p. 20-26.

Research output: Contribution to journalArticle

Ursini, CL, Omodeo Salè, E, Fresegna, AM, Ciervo, A, Jemos, C, Maiello, R, Buresti, G, Colosio, C, Rubino, FM, Mandić-Rajčević, S, Chiarella, P, Carbonari, D, Delrio, P, Maiolino, P, Marchetti, P, Boccia, R, Iavicoli, S & Cavallo, D 2019, 'Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker', Toxicology Letters, vol. 316, pp. 20-26. https://doi.org/10.1016/j.toxlet.2019.08.022
Ursini, C. L. ; Omodeo Salè, E. ; Fresegna, A. M. ; Ciervo, A. ; Jemos, C. ; Maiello, R. ; Buresti, G. ; Colosio, C. ; Rubino, F. M. ; Mandić-Rajčević, Stefan ; Chiarella, P. ; Carbonari, D. ; Delrio, P. ; Maiolino, P. ; Marchetti, P. ; Boccia, R. ; Iavicoli, S. ; Cavallo, D. / Antineoplastic drug occupational exposure : a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker. In: Toxicology Letters. 2019 ; Vol. 316. pp. 20-26.
@article{afacec2ecef4485284f510c2769edbfa,
title = "Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker",
abstract = "Health-care personnel handling antineoplastic drugs could be at risk for adverse health effects. We aimed to evaluate genotoxic and cytotoxic effects of antineoplastic drug exposure of personnel preparing and administering such drugs in three Oncology Hospitals in Italy enrolling 42 exposed subjects and 53 controls. Furthermore, we aimed to study the possible influence of XRCC1 and hOGG1 DNA repair genes polymorphisms on genotoxicity induced on buccal cells. We performed workplace and personal monitoring of some drugs and used exposure diary informations to characterize the exposure. Urinary 5-FU metabolite (α-fluoro-β-alanine) was measured. Buccal Micronucleus Cytome (BMCyt) assay was used to evaluate DNA damage and other cellular anomalies. GEM and 5-FU contamination was found in 68{\%} and 42{\%} of wipe/swab samples respectively. GEM deposition was found on workers’ pads while no α-fluoro-β-alanine was found. BMCyt-assay showed higher genotoxicity and cytotoxicity on nurses administering antineoplastics than on preparators and controls. Among micronucleus (MN) positive (with MN frequency higher than 1.5‰) exposed subjects, the percentage of those carrying XRCC1 mut/het genotype was higher than in MN positive-controls. Using the sensitive BMCyt assay, we demonstrated that handling antineoplastics still represents a potential occupational health risk for workers that should be better trained/informed regarding such risks.",
keywords = "Antineoplastic drug handling, Buccal micronucleus cytome (BMCyt) assay, Nurses, Workplace monitoring",
author = "Ursini, {C. L.} and {Omodeo Sal{\`e}}, E. and Fresegna, {A. M.} and A. Ciervo and C. Jemos and R. Maiello and G. Buresti and C. Colosio and Rubino, {F. M.} and Stefan Mandić-Rajčević and P. Chiarella and D. Carbonari and P. Delrio and P. Maiolino and P. Marchetti and R. Boccia and S. Iavicoli and D. Cavallo",
year = "2019",
month = "11",
day = "1",
doi = "10.1016/j.toxlet.2019.08.022",
language = "English",
volume = "316",
pages = "20--26",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Antineoplastic drug occupational exposure

T2 - a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker

AU - Ursini, C. L.

AU - Omodeo Salè, E.

AU - Fresegna, A. M.

AU - Ciervo, A.

AU - Jemos, C.

AU - Maiello, R.

AU - Buresti, G.

AU - Colosio, C.

AU - Rubino, F. M.

AU - Mandić-Rajčević, Stefan

AU - Chiarella, P.

AU - Carbonari, D.

AU - Delrio, P.

AU - Maiolino, P.

AU - Marchetti, P.

AU - Boccia, R.

AU - Iavicoli, S.

AU - Cavallo, D.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Health-care personnel handling antineoplastic drugs could be at risk for adverse health effects. We aimed to evaluate genotoxic and cytotoxic effects of antineoplastic drug exposure of personnel preparing and administering such drugs in three Oncology Hospitals in Italy enrolling 42 exposed subjects and 53 controls. Furthermore, we aimed to study the possible influence of XRCC1 and hOGG1 DNA repair genes polymorphisms on genotoxicity induced on buccal cells. We performed workplace and personal monitoring of some drugs and used exposure diary informations to characterize the exposure. Urinary 5-FU metabolite (α-fluoro-β-alanine) was measured. Buccal Micronucleus Cytome (BMCyt) assay was used to evaluate DNA damage and other cellular anomalies. GEM and 5-FU contamination was found in 68% and 42% of wipe/swab samples respectively. GEM deposition was found on workers’ pads while no α-fluoro-β-alanine was found. BMCyt-assay showed higher genotoxicity and cytotoxicity on nurses administering antineoplastics than on preparators and controls. Among micronucleus (MN) positive (with MN frequency higher than 1.5‰) exposed subjects, the percentage of those carrying XRCC1 mut/het genotype was higher than in MN positive-controls. Using the sensitive BMCyt assay, we demonstrated that handling antineoplastics still represents a potential occupational health risk for workers that should be better trained/informed regarding such risks.

AB - Health-care personnel handling antineoplastic drugs could be at risk for adverse health effects. We aimed to evaluate genotoxic and cytotoxic effects of antineoplastic drug exposure of personnel preparing and administering such drugs in three Oncology Hospitals in Italy enrolling 42 exposed subjects and 53 controls. Furthermore, we aimed to study the possible influence of XRCC1 and hOGG1 DNA repair genes polymorphisms on genotoxicity induced on buccal cells. We performed workplace and personal monitoring of some drugs and used exposure diary informations to characterize the exposure. Urinary 5-FU metabolite (α-fluoro-β-alanine) was measured. Buccal Micronucleus Cytome (BMCyt) assay was used to evaluate DNA damage and other cellular anomalies. GEM and 5-FU contamination was found in 68% and 42% of wipe/swab samples respectively. GEM deposition was found on workers’ pads while no α-fluoro-β-alanine was found. BMCyt-assay showed higher genotoxicity and cytotoxicity on nurses administering antineoplastics than on preparators and controls. Among micronucleus (MN) positive (with MN frequency higher than 1.5‰) exposed subjects, the percentage of those carrying XRCC1 mut/het genotype was higher than in MN positive-controls. Using the sensitive BMCyt assay, we demonstrated that handling antineoplastics still represents a potential occupational health risk for workers that should be better trained/informed regarding such risks.

KW - Antineoplastic drug handling

KW - Buccal micronucleus cytome (BMCyt) assay

KW - Nurses

KW - Workplace monitoring

UR - http://www.scopus.com/inward/record.url?scp=85071944619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071944619&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2019.08.022

DO - 10.1016/j.toxlet.2019.08.022

M3 - Article

C2 - 31465813

AN - SCOPUS:85071944619

VL - 316

SP - 20

EP - 26

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

ER -